The University of Southampton
University of Southampton Institutional Repository

Synthetic studies towards natural products as potential treatment for liver fibrosis

Synthetic studies towards natural products as potential treatment for liver fibrosis
Synthetic studies towards natural products as potential treatment for liver fibrosis

Whether your liver is infected with a virus, injured by chemicals or under attack from your own immune system, the damage to your liver is likely to progress in a similar way. In the early stages of liver disease, your liver becomes inflamed. If left untreated, the inflamed liver will start to scar. As excess scar tissue grows, it replaces the healthy liver tissues. This process is called fibrosis. MBP039-06, a natural product isolated and patented by Mitsubishi Pharmaceuticals, and dithiosilvatin a member of the epipolydithiodiketopiperazine alkoliod family, have evidence to indicate them as potential treatments for liver fibrosis. We report the total synthesis ofMBP039-06 and its absolute configuration, utilising the Lacey-Dieckmann condensation. Both enantiomers were prepared, and comparison of CD spectra with those of the naturally isolated material have enabled its absolute configuration to be established. In addition we report the synthesis of a small library of tetramic acid analogues. In our investigation we have shown MBP039-06 to be an effective inhibitor of HIF proyl hydroxylase. Inhibitors of this kind offer potential new therapies in ischaemicl hypoxic disease. In the second part of the thesis we report our work completed towards the total synthesis of dithiosilvatin, concentrating on an unnatural amino acid approach to the synthesis. We have established routes to a range of bis protected dithiodiketopiperazines, an important intermediate III the synthesis of the epipolydithiodiketopiperazine core. In addition we have discovered and disclose the structure of two novel potent inhibitors ofLys9-specific histone methyltransferase G9a. Methyltransferases are misregulated in tumors and are involved in neurodegenerative diseases such as Alzheimer's.

University of Southampton
Pitt, Gary Robert William
75616d06-e849-470d-844c-f93c9763e90d
Pitt, Gary Robert William
75616d06-e849-470d-844c-f93c9763e90d

Pitt, Gary Robert William (2008) Synthetic studies towards natural products as potential treatment for liver fibrosis. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Whether your liver is infected with a virus, injured by chemicals or under attack from your own immune system, the damage to your liver is likely to progress in a similar way. In the early stages of liver disease, your liver becomes inflamed. If left untreated, the inflamed liver will start to scar. As excess scar tissue grows, it replaces the healthy liver tissues. This process is called fibrosis. MBP039-06, a natural product isolated and patented by Mitsubishi Pharmaceuticals, and dithiosilvatin a member of the epipolydithiodiketopiperazine alkoliod family, have evidence to indicate them as potential treatments for liver fibrosis. We report the total synthesis ofMBP039-06 and its absolute configuration, utilising the Lacey-Dieckmann condensation. Both enantiomers were prepared, and comparison of CD spectra with those of the naturally isolated material have enabled its absolute configuration to be established. In addition we report the synthesis of a small library of tetramic acid analogues. In our investigation we have shown MBP039-06 to be an effective inhibitor of HIF proyl hydroxylase. Inhibitors of this kind offer potential new therapies in ischaemicl hypoxic disease. In the second part of the thesis we report our work completed towards the total synthesis of dithiosilvatin, concentrating on an unnatural amino acid approach to the synthesis. We have established routes to a range of bis protected dithiodiketopiperazines, an important intermediate III the synthesis of the epipolydithiodiketopiperazine core. In addition we have discovered and disclose the structure of two novel potent inhibitors ofLys9-specific histone methyltransferase G9a. Methyltransferases are misregulated in tumors and are involved in neurodegenerative diseases such as Alzheimer's.

Text
1234458.pdf - Version of Record
Available under License University of Southampton Thesis Licence.
Download (5MB)

More information

Published date: 2008

Identifiers

Local EPrints ID: 466625
URI: http://eprints.soton.ac.uk/id/eprint/466625
PURE UUID: 6e0fb994-0414-420f-81d8-c0c9ac2b3cd8

Catalogue record

Date deposited: 05 Jul 2022 06:06
Last modified: 16 Mar 2024 20:49

Export record

Contributors

Author: Gary Robert William Pitt

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×